CADDRA ADHD Updates • February 2024

caddra.ca

February 2024

Update

CADDRA is a Canadian non-profit member association for medical and health care professionals, along with researchers, who assess, treat and/or study ADHD.

Fairmont Winnipeg

Winnipeg, Manitoba

Submission Portal Now Open!

Do you have a Presentation in Mind?

Access the portal at caddra.joynconference.com

11th Annual

ADHD Research Day

Friday, September 27

20th Annual

ADHD Conference

Saturday, September 28

& Sunday, September 29

Add this Event to your Calendar

Highlighted Abstract

Journal articles are selected based on their clinical relevance. The commentary reflects the reviewer’s own opinion and is not approved, or necessarily representative, of the opinion of the CADDRA Board.

This month’s abstract was selected by CADDRA Advisory Council member, Natalie Grizenko MD, FRCPC*. Dr. Grizenko is a psychiatrist and the Medical Chief of the ADHD clinic and Severe Disruptive Behaviour Disorders Program at the Douglas Institute and an Associate Professor at McGill University.

Is there evidence of a causal link between childhood maltreatment and attention deficit/hyperactivity disorder? A systematic review of prospective longitudinal studies using the Bradford-Hill criteria

Paraskevi Bali, Edmund Sonuga-Barke, Christina Mohr-Jensen, Ditte Demontis, Helen Minnis

Read the PDF

Commentary by *Dr. Natalie Grizenko: This is an interesting article that explores the possible link between childhood maltreatment and ADHD and highlights the complexity of examining such a link.

Current ADHD Research

Please note: These are links to research abstracts. Some are available without cost and others require a subscription.

The Adult ADHD Assessment Quality Assurance Standard (AQAS). Adamou1l, Marios, et al.

Economic Burden and Service Utilization of Children With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. Dodds, Mitchell, et al. Value in Health 27.2 (2024): 247-264.

Biederman’s Contribution to the Understanding of Executive Function in ADHD. Schachar, Russell, and Jennifer Crosbie. Journal of Attention Disorders (2024): 10870547231222597.

Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. Farhat, Luis C., et al. JAMA Psychiatry (2023).

Stimulant medication and suicide mortality in attention-deficit hyperactivity disorder. Rice, Korie M., et al. BJPsych Open 10.1 (2024): e33.

Diagnostic Utility of Conners Continuous Performance Test-3 for Attention Deficit/Hyperactivity Disorder: A Systematic Review. Callan, P. Douglas, et al. Journal of Attention Disorders (2024): 10870547231223727.

Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children. Suarez, Elizabeth A., et al. JAMA Psychiatry (2024).

Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis. Tadesse, Abay Woday, et al. Journal of Psychiatric Research 171 (2024): 142-151.

2024 Young Investigator Grants

The Brain & Behavior Research Foundation has announced the opening of applications for the 2024 BBRF Young Investigator Grant.

Nomination deadline

March 12, 2024

FIND OUT MORE

Brain Sciences is now accepting nominations for the Brain Sciences 2024 Young Investigator Award, which will be given to one young investigator in recognition of their excellence in the field of neuroscience.

Nomination deadline

March 31, 2024

FIND OUT MORE

Digital Health Canada

CADDRA is now a member of Digital Health Canada, a not-for-profit professional association that connects, inspires, and empowers those enabling digital healthcare in Canada.

Membership in this network provides CADDRA with information and support as it continues to develop and expand its digital tools and resources for healthcare practitioners, such as ADHD TrEAT and ADHDLearn.